Are you familiar with AI and blockchain? As a stakeholder in healthcare, if you’re not you soon will be, according to Dr. Kala Fleming, an innovation leader at IBM. Fleming, a research scientist, strategist, engineer, and tech startup and hackathon advisor known for designing and implementing initiatives that drive adoption of next-generation technologies, works on digital inclusion across the Caribbean, Africa, and in underserved communities in the U.S. “I also work directly with entrepreneurs, advising on their startups, connecting them to resources or helping them apply emerging technologies like AI and blockchain,” she says. [Read more…]
Fate Therapeutics and ONO Pharmaceutical to Develop Off-the-Shelf, iPSC-derived CAR-T Cell Cancer Immunotherapies
Option-based Collaboration to Develop Two CAR T-Cell Product Candidates Using Fate’s Proprietary iPSC Product Platform
SAN DIEGO, Sept. 17, 2018 — Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today that it has entered into a collaboration with ONO Pharmaceutical Co., Ltd. for the joint development and commercialization of two off-the-shelf CAR-T cell product candidates. Using Fate Therapeutics’ proprietary induced pluripotent stem cell (iPSC) product platform, the two CAR T-cell collaboration candidates will each be derived from a clonal master iPSC line engineered to completely eliminate endogenous TCR expression, insert a chimeric antigen receptor (CAR) into the TRAC locus and incorporate other anti-tumor functionality. [Read more…]
Your Ultimate Guide to Cell and Gene Therapy Conferences
Cell and gene therapy conferences have been rapidly multiplying over the past decade. This article is your ultimate guide to cell and gene therapy conferences worldwide. These conferences include presentations on stem cells, CAR-T, exosomes, and other types of cell and gene therapy applications.
Our goal is for this to be a comprehensive guide to cell and gene therapy events worldwide, so we welcome new additions in the comments below. [Read more…]
Unicyte and Collaboration Partner Prof. Camussi Achieve Preclinical Milestone in Diabetes Program
Unicyte, a regenerative medicine unit of Fresenius Medical Care, and its collaboration partner Professor Camussi have published results in Stem Cell Reviews and Reports that a potential therapeutic strategy for diabetes is the transplantation of induced-insulin secreting cells.
The Global Disease Burden of Diabetes Mellitus
Diabetes mellitus is one of the most common diseases globally. Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. With an aging population and surging rates of obesity, the incidence of this debilitating disease on the rise. [Read more…]
Bahamas Summit to Take Deep Dive into Stem Cell Innovation and Digital Health
There’s a new arena for stem cell innovation and digital health advancement. Believe it or not, it’s replete with crystal clear waters and powder white sands. It’s called the 2018 HEALinc Future Health Innovation Summit.
The Summit is hosted in The Bahamas, a safe haven for intellectual property discussions and home to progressive legislation in the region promoting stem cell research. With an impressive faculty of the best and brightest minds in translational medicine, the Summit is a “must attend” event. [Read more…]
- « Previous Page
- 1
- …
- 53
- 54
- 55
- 56
- 57
- …
- 62
- Next Page »